Drug Development Solutions
-
Gene Therapy Capabilities For AAV And Lentivirus Production
Explore all of our gene therapy solutions for AAV and Lentivirus manufacturing based on 30+ years of experience to help bring your therapy to life.
-
Resin Offering High Productivity And Robust Processes
5/3/2023
MabSelect™ VL affinity resin uses a protein L ligand with strong affinity for the variable region of a human antibody’s kappa light chain. The resin offers high productivity and robust processes for affinity capture of bispecific antibodies and antibody fragments containing the kappa light chain and offers a good capture alternative for antibody variants that does not bind to protein A.
-
HyClone Cell Boost 1 Supplement
9/21/2020
Improve productivity and cell growth in fed-batch cultures by supplementing the cell culture medium to boost nutrients depleted during culture. HyClone™ Cell Boost™ 1 Supplement provides nutrients such as amino acids and glucose that are suitable for research and bioprocessing applications.
-
Comprehensive Services CNS Drug Development
4/9/2024
Our approach is designed to optimize efficiency and accelerate timelines, resulting in up to 40% time savings throughout the early phases of your drug development journey.
-
Meeting The Unique Needs Of Your Sterile Injectable With Exact SI-ence
Explore how a CDMO with dedicated quality and analytical teams, robust processes, and specialized technologies can help support your sterile injectable product from clinical to commercial.
-
HyClone Cell Boost 3 Supplement
9/21/2020
Improve productivity and cell growth in fed-batch cultures by supplementing the cell culture medium to boost nutrients depleted during culture. HyClone™ Cell Boost™ 3 Supplement provides nutrients such as amino acids, glucose, and trace elements that are suitable for research and bioprocessing applications.
-
Antibody Drug Conjugates: Link Your Antibody To Its Fullest Potential
Learn how our parallel development service works seamlessly with our existing antibody capabilities, helping to accelerate your ADC program and reach market faster.
-
Mammalian Cell Culture: Process R&D Services
Lonza’s global R&D center for mammalian cell processes is based in Slough, UK alongside a custom manufacturing facility. Lonza undertakes highly specialized development and manufacturing services for the pharmaceutical and biotechnology industries. Read more about Lonza’s complete range of R&D Services and an array of technologies and skills to best match their customers’ requirements for all stages of product development.
-
UpTempo℠ AAV Platform Process
Catalent’s UpTempo℠ AAV platform process is a scalable, cGMP-ready process for viral vector manufacturing that can reduce the current 18-20-month development timeline for drug product in half.
-
IDT Biologika - End-to-End Services In Vaccines, CGTs, And Biologics
7/25/2023
IDT Biologika provides end-to-end services in contract development and manufacturing of vaccines, cell & gene therapeutics, and fill-finish of biologics.